Edwards Lifesciences Corporation (EW)

NYSE: EW · IEX Real-Time Price · USD

86.50

+0.69 (0.80%)

At close: Jul 19, 2024, 4:00 PM

86.73

+0.23 (0.27%)

Pre-market: Jul 22, 2024, 7:53 AM EDT

Edwards Lifesciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1997
Net Income	1,414	1,402	1,522	1,503	823.4	1,047	Upgrade
Depreciation & Amortization	177.3	173.1	166.8	163.3	135.4	114.6	Upgrade
Share-Based Compensation	145.1	139.4	126.8	109.3	92.6	81.3	Upgrade
Other Operating Activities	-1,208	-819.1	-597.3	-43.6	2.9	-59.9	Upgrade
Operating Cash Flow	528.2	895.8	1,218	1,732	1,054	1,183	Upgrade
Operating Cash Flow Growth	-57.37%	-26.47%	-29.67%	64.29%	-10.87%	27.65%	Upgrade
Capital Expenditures	-256.8	-253	-244.6	-325.8	-407	-254.4	Upgrade
Acquisitions	20.2	-125.2	-109.6	-13.1	-10	-135.2	Upgrade
Change in Investments	506.1	577.8	655.5	-1,335.2	-101.7	-171.1	Upgrade
Other Investing Activities	-33.1	-25.8	-49	-48.4	-12.4	-35.1	Upgrade
Investing Cash Flow	236.4	173.8	252.3	-1,722.5	-531.1	-595.8	Upgrade
Share Issuance / Repurchase	-440.4	-709.7	-1,580.7	-354.2	-484.9	-102.8	Upgrade
Debt Issued / Paid	-0.3	-0.3	-0.2	-1.8	-0.8	-10	Upgrade
Other Financing Activities	-2	-1	-3.6	-0.3	-1.2	-2.8	Upgrade
Financing Cash Flow	-442.7	-711	-1,584.5	-356.3	-486.9	-115.6	Upgrade
Exchange Rate Effect	30.7	16.8	19.2	13.9	-20.5	-3	Upgrade
Net Cash Flow	352.6	375.4	-94.8	-332.8	15.8	468.5	Upgrade
Free Cash Flow	271.4	642.8	973.6	1,406	647.3	928.5	Upgrade
Free Cash Flow Growth	-73.01%	-33.98%	-30.77%	117.26%	-30.29%	34.96%	Upgrade
Free Cash Flow Margin	4.42%	10.70%	18.09%	26.88%	14.76%	21.35%	Upgrade
Free Cash Flow Per Share	0.45	1.06	1.57	2.26	1.04	1.49	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).